Distribution and metabolism of four different dimethylated arsenicals in hamsters

Toxicology and Applied Pharmacology

Volumn 245, Issue 1, 2010, Pages 67-75

  Naranmandura, Hua ^a,b   Iwata, Katsuya ^b   Suzuki, Kazuo T ^b   Ogra, Yasumitsu ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b CHIBA UNIVERSITY   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Arsenic; Dimethylarsinic acid; Dimethyldithioarsinic acid; Dimethylmonothioarsinic acid; Thioarsenic; Thioarsenical

Indexed keywords

ARSENIC; ARSINIC ACID DERIVATIVE; CACODYLIC ACID; DIMETHYLARSINOUS ACID; DIMETHYLDITHIOARSINIC ACID; DIMETHYLMONOTHIOARSINIC ACID; ORGANOARSENIC DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; ERYTHROCYTE; HAMSTER; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MALE; MUSCLE TISSUE; NONHUMAN; TOXICOKINETICS; URINARY EXCRETION;

ANIMALS; CACODYLIC ACID; CRICETINAE; ERYTHROCYTES; KIDNEY; LIVER; LUNG; MALE; MESOCRICETUS; SKIN;

ANIMALIA; CRICETINAE;

EID: 77952550798     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.02.001     Document Type: Article

References (43)

1. Adair B.M., Moore T., Conklin S.D., Creed J.T., Wolf D.C., Thomas D.J. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats. Toxicol. Appl. Pharmacol. 2007, 222:235-342.
2. Charbonneau S.M., Hollins J.G., Tam G.K., Bryce F., Ridgeway J.M., Willes R.F. Whole-body retention, excretion and metabolism of [74As] arsenic acid in the hamster. Toxicol. Lett. 1980, 5:175-182.
3. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., St, John M., Yamamoto S., Lu X., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 2003, 15:1150-1157.
4. Drobná Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., Stỳblo M. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 2005, 207:147-159.
5. Engel R.R., Hopenhayn Rich C., Receveur O., Smith A.H. Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 1994, 16:184-209.
6. Hirano S., Cui X., Li S., Kanno S., Kobayashi Y., Hayakawa T., Shraim A. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 2003, 77:305-312.
7. Hirano S., Kobayashi Y., Cui X., Kanno S., Hayakawa T., Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol. Appl. Pharmacol. 2004, 198:458-467.
8. Hughes M.F., Kenyon E.M., Edwards B.C., Mitchell C.T., Del Razo L.M., Thomas D.J. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol. Appl. Pharmacol. 2003, 191:202-210.
9. Hughes M.F., Devesa V., Adair B.M., Conklin S.D., Creed J.T., Styblo M., Kenyon E.M., Thomas D.J. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. Toxicol. Appl. Pharmacol. 2008, 227:26-35.
10. Kligerman A.D., Doerr C.L., Tennant A.H., Harrington-Brock K., Allen J.W., Winkfield E., Poorman-Allen P., Kundu B., Funasaka K., Roop B.C., Mass M.J., DeMarini D.M. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of As: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 2003, 42:192-205.
11. Kubachka K.M., Kohan M.C., Herbin-Davis K., Creed J.T., Thomas D.J. Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. Toxicol. Appl. Pharmacol. 2009, 239:137-143.
12. Lee T.C., Ho I.C., Lu W.J., Huang J.D. Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J. Biol. Chem. 2006, 281:18401-18407.
13. Lu M., Wang H., Li X.F., Lu X., Cullen WR., Arnold L.L., Cohen S.M., Le X.C. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 2004, 17:1733-1742.
14. Lu M., Wang H., Li X.F., Arnold L.L., Cohen S.M., Le X.C. Binding of dimethylarsinous acid to cys-13α of rat hemoglobin is responsible for the retention of arsenic in rat blood. Chem. Res. Toxicol. 2007, 20:27-37.
15. Mandal B.K., Suzuki K.T. Arsenic round the world: a review. Talanta 2002, 58:201-235.
16. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic affected areas in West Bengal, India. Chem. Res. Toxicol. 2001, 14:371-378.
17. Mandal B.K., Suzuki K.T., Anzai K., Yamaguchi K., Sei Y. A SEC-HPLC-ICP MS hyphenated technique for identification of sulfur-containing arsenic metabolites in biological samples. J. Chromatogr. B. 2008, 874:64-76.
18. Marafante E., Vahter M., Norin H., Envall J., Sandström M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 1987, 7:111-117.
19. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 2001, 14:355-361.
20. Naranmandura H., Suzuki K.T. Formation of dimethylthioarsenicals in red blood cells. Toxicol. Appl. Pharmacol. 2008, 227:390-399.
21. Naranmandura H., Suzuki N., Suzuki K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 2006, 19:1010-1018.
22. Naranmandura H., Ibata K., Suzuki K.T. Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells. Chem. Res. Toxicol. 2007, 20:1120-1125.
23. Naranmandura H., Suzuki N., Iwata K., Hirano K., Suzuki K.T. Arsenic metabolism and thioarsenicals in hamsters and rats. Chem. Res. Toxicol. 2007, 20:616-624.
24. Naranmandura H., Ogra Y., Iwata K., Lee J., Suzuki K.T., Weinfeld M., Le X.C. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol. Appl. Pharmacol. 2009, 238:133-140.
25. Arsenic in Drinking Water 1999, National Research Council (NRC)., National Academy Press, Washington, D.C.
26. Arsenic in Drinking Water 2001 Update 2001, National Research Council (NRC)., National Academy Press, Washington, D.C.
27. Ochi T., Kita K., Suzuki T., Rumpler A., Goessler W., Francesconi K.A. Cytotoxic, genotoxic and cell-cycle disruptive effects of thio-dimethylarsinate in cultured human cells and the role of glutathione. Toxicol. Appl. Pharmacol. 2008, 228:59-67.
28. Pomroy C., Charbonneau S.M., McCullough R.S., Tam G.K.H. Human retention studies with 74As. Toxicol. Appl. Pharmacol. 1980, 53:550-556.
29. Raml R., Rumpler A., Goessler W., Vahter M., Li L., Ochi T., Francesconi K.A. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. 2007, 222:374-380.
30. III) by red blood cells. Chem. Res. Toxicol. 2001, 14:1446-1452.
31. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
32. Suzuki K.T., Mandal B.K., Ogra Y. Speciation of arsenic in body fluids. Talanta 2002, 58:111-119.
33. Suzuki K.T., Katagiri A., Sakuma Y., Ogra Y., Ohmichi M. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Appl. Pharmacol. 2004, 198:336-344.
34. Suzuki K.T., Mandal B.K., Katagiri A., Sakuma Y., Kawakami A., Ogra Y., Yamaguchi K., Sei Y., Yamanaka K., Anzai M., Ohmichi H., Takayama H., Aimi N. Dimethylthioarsenicals as arsenic metabolites and their chemical preparation. Chem. Res. Toxicol. 2004, 17:914-921.
35. Suzuki K.T., Iwata K., Naranmandura H., Suzuki N. Metabolic differences between two dimethylthioarsenicals in rats. Toxicol. Appl. Pharmacol. 2007, 218:166-173.
36. Suzuki N., Naranmandura H., Hirano S., Suzuki K.T. Theoretical calculations and reaction analysis on the interaction of pentavalent thioarsenicals with biorelevant thiol compounds. Chem. Res. Toxicol. 2008, 21:550-553.
37. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999, 82:69-88.
38. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 1983, 47:29-44.
39. Vahter M., Marafante E., Dencker L. Tissue distribution and retention of 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 1984, 13:259-264.
40. van Gemert M., Eldan M. Chronic carcinogenicity assessment of cacodylic acid. Third International Conference on Arsenic Exposure and Health Effects 1998, 113. San Diego, CA.
41. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 1999, 20:1873-1876.
42. Yamanaka K., Kato K., Mizoi M., An Y., Takabayashi F., Nakano M., Hoshino M., Okada S. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol. Appl. Pharmacol. 2004, 198:385-393.
43. Yamauchi H., Yamamura Y. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 1984, 74:134-140.